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The impact of COVID-19 
on antimalarial supply 
chains in Ghana
The COVID-19 crisis has indirectly 
affected health-care provision and 
outcomes for many non-COVID-19 
conditions. Our research in Ghana 
suggests that the COVID-19 pandemic 
might be reducing the availability 
of antimalarials in private sector 
pharmacies and over-the-counter 
(OTC) medicine outlets, which are 
major sources of essential medicines.
As part of a larger project 
tracing antimalarial supply chains 
in Africa, we collected data on 
antimalarial medicines available 
at 89 licensed outlets across four 
regions of Ghana (Savannah 
[22 outlets], Volta [23 outlets], 
Upper East [22 outlets], and Western 
North [22 outlets]) using a two-
stage stratified sampling procedure. 
The sample comprised 23 retail 
pharmacies and 66 OTC medicine 
outlets (38 were in urban locations 
and 51 in rural locations). The data 
were collected between Sept 1, 2020, 
and Dec 20, 2020, when there was a 
high number of people with COVID-19 
in Ghana (44 460 on Sept 1, 2020, 
increasing to 54 043 by Dec 25, 2020).1 
Although not part of our original 
study design, we questioned store 
managers on the perceived effects of 
the COVID-19 pandemic on medicine 
supplies. Specifically, we asked store 
managers whether their antimalarial 
supplies had increased, decreased, or 
remained the same since the start of 
the COVID-19 pandemic.
Altogether, 45 of 89 participants 
reported that their supplies of 
antimalarials had decreased since 
the start of the COVID-19 pandemic, 
42 participants reported no change, 
and two reported that some supplies 
had increased and others had 
decreased. This pattern was broadly 
consistent across pharmacies and 
OTC medicine outlets and between 
rural and urban areas. However, there 
were significant regional differences. 
Six of 23 outlets in Volta (close to 
Accra the capital city) reported a 
worsening supply since the start of the 
COVID-19 pandemic, compared with 
ten of 22 outlets in Savannah, 14 of 
22 in Western North, and 15 of 22 in 
Upper East (p=0·021 [χ² test]).
Our findings should be interpreted 
with caution—we sampled just four 
of the 16 regions in Ghana and the 
data were self reported, relying on 
recall of the pre-pandemic situation, 
and represented a snapshot of one 
point in time, precluding additional 
longitudinal analysis. Nonetheless, 
the picture is alarming and suggests 
that the impact of the COVID-19 
pandemic on the health of Ghanaians 
could be far reaching. Regional 
disparities, with areas further from 
the capital (Accra; the main port of 
entry and manufacture of medicines) 
disproportionately affected by the 
COVID-19 pandemic, compounded 
existing inequalities in health-care 
provision across the country.2
This research is funded by the UK Medical Research 
Council. We declare no competing interests.
Copyright © 2020 The Author(s). Published by 
Elsevier Ltd. This is an Open Access article under the 
CC BY 4.0 license.
Kate Hampshire, Liz David-Barrett, 
Adams Osman, Simon Mariwah, 
*Heather Hamill
heather.hamill@sociology.ox.ac.uk
Department of Anthropology, Durham University, 
Durham, UK (KH); School of Law, Politics and 
Sociology, University of Sussex, Brighton, UK 
(LD-B); Department of Geography Education, 
University of Education, Winneba, Ghana (AO); 
School of Geography and Regional Planning, 
University of Cape Coast, Cape Coast, Ghana (SM); 
Department of Sociology, University of Oxford, 
Oxford OX1 1JD, UK (HH)
1 Sasu DD. Cumulative number of confirmed 
coronavirus cases (COVID-19) in Ghana as of 




2 Ghana Health Service. The health sector in 
Ghana. Facts and figures. 2018. 
https://ghanahealthservice.org/downloads/
Facts+Figures_2018.pdf (accessed 
June 21, 2021).
